INBS vs JLL · rev $4.2M vs P/E 23, rev $13.31B
Intelligent Bio Solutions Inc. (INBS) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
Intelligent Bio Solutions Inc. (INBS) is a medical devices company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported INBS revenue for 2026-06-30 was $4.2M. Net income was -$12.4M. Revenue was up 38.1% from 2025-06-30 to 2026-06-30. INBS currently screens at market cap $5.9M.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
INBS currently screens at market cap $5.9M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the INBS and JLL stock pages for the full models.
Not investment advice.